Vascular endothelial growth factor and hypertrophic osteoarthropathy

Clinical and Experimental Rheumatology

Volumn 18, Issue 1, 2000, Pages 57-62

  Silveira, L H ^a   Martinez Lavin M ^a   Pineda, C ^a   Fonseca, M C ^b   Navarro, C ^b   Nava, A ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Cyanotic heart disease; Hypertrophic osteoarthropathy; Lung cancer; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTROPHIC OSTEOARTHROPATHY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; LUNG DISEASES, OBSTRUCTIVE; LUNG NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC; OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0343986379     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. MARTÍNEZ-LAVÍN M: Hypertrophic osteoarthropathy. In KLIPPEL J and DIEPPE P (Eds.): Rheumatology, 2nd ed., St Louis, Mosby; 1998; 8.46.1-4.
2. BIGLER FC: The morphology of clubbing. Am J Pathol 1958; 34: 237-61.
3. MENDLOWITZ M: Clubbing and hypertrophic osteoarthropathy. Medicine 1942; 21: 269-306.
4. MATUCCI-CERINIC M, CINTI S, MORRONI M, et al.: Pachydermoperiostosis (primary hypertrophic osteoarthropathy): Report of a case with evidence of endothelial and connective tissue involvement. Ann Rheum Dis 1989; 240-6.
5. JAJIC I, PECINA M, KRSTULOVIC B, KOVACEVIC D, PAVICIC F, SPAVENTI S: Primary hypertrophic osteoarthropathy and changes in the joints. Scand J Rheumatol 1980; 9: 89-96.
6. VAZQUEZ-ABAD D, MARTÍNEZ-LAVÍN M: Macrothrombocytes in the peripheral circulation of patients with cardiogenic hypertrophic osteoarthropathy. Clin Exp Rheumatol 1991; 9: 59-62.
7. MATUCCI-CERINIC M, MARTÍNEZ-LAVÍN M, ROJO F, FONSECA C, KAHALEH B: von Willebrand factor antigen in hypertrophic osteoarthropathy. J Rheumatol 1992; 19: 765-7.
8. MARTÍNEZ-LAVÍN M: Digital clubbing and hypertrophic osteoarthropathy: A unifying hypothesis. J Rheumatol 1987; 14: 6-8.
9. THOMAS KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996; 271: 603-6.
10. MOHLE R, GREEN D, MOORE MA, NACHMAN RL, RAFII S: Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Nat Acad Sci USA 1997; 94: 663-8.
11. SCHIEBOUT-CLARK RC, HAVEN MC, HAIRE WD, WILSON RB, MARKIN RS: Filtration of platelet-poor plasma specimens yields platelet-free plasma. Application for batch analysis of beta-thromboglobulin and platelet factor 4. Am J Clin Pathol 1990; 94: 206-10.
12. FONSECA C, MARTÍNEZ-LAVÍN M, HERNANDEZ-RODRIGUEZ N, OSORNIO-VARGAS A: Circulating plasma levels of platelet-derived growth factor in patients with hypertrophic osteoarthropathy (abstract). Clin Exp Rheumatol 1992; 10 (Suppl. 7): 73.
13. SILVERI F, DE ANGELIS R, ARGENTATI F, BRECCIAROLI D, MUTI S, CERVINI C: Hypertrophic osteoarthropathy: endothelium and platelet function. Clin Rheumatol 1996; 15: 435-9.
14. HIRAKATA Y, KITAMURA S: Elevated serum transforming growth factor beta-1 level in primary lung cancer patients with finger clubbing. Eur J Clin Invest 1996; 26: 820-3.
15. HOJO S, FUJITA J, YAMADORI I et al.: Hepatocyte growth factor and digital clubbing. Intern Med 1997; 36: 44-6.
16. HARADA S, NAGY JA, SULLIVAN KA et al.: Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93: 2490-6.
17. MIDY V, PLOUET J: Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 1994; 199: 380-6.
18. WATANABE O, ARIMURA K, KITAJIMA I, OSEMA M, MURAYAMA I: Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome (letter). Lancet 1996; 347: 702.
19. SOUBRIER M, DUBOST JJ, SERRE AF et al.: Growth factors in POEMS syndrome: Evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997; 40: 786-7.
20. MARTÍNEZ-LAVÍN M, VARGAS AS, CABRÉ C et al.: Features of hypertrophic osteoarthropathy in patients with POEMS syndrome: A metaanalysis. J Rheumatol 1997; 24: 2267-8.
21. KONIG JE, TOLNAY E, WIETHEGE T, MULLER KM: Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma. Virchows Arch 1999; 435: 8-12.
22. SATO K, YAMAZAKI K, SHIZUME K et al.: Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo. J Clin Invest 1995; 96: 1295-302.
23. GRIGA T, VOIGT E, GRETZER B, BRASCH F, MAY B: Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 1999; 46: 920-3.